Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
media
posted on 2021-01-25, 10:26 authored by Adis journals on behalf of, Dan J. Stein, Jon-Paul Khoo, Françoise Picarel-Blanchot, Valérie Olivier, Michael Van Ameringen<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021. </p>
